HealthcareDiffusion Pharma short of Nasdaq listing requirementsMay 26, 2017 4:20 PM ETCervoMed Inc. (CRVO) StockCRVOBy: Douglas W. House, SA News EditorNasdaq notifies Diffusion Pharmaceuticals (NASDAQ:DFFN) that it no longer meets listing requirements for minimum market value ($35M) and minimum stockholders' equity ($2.5M). The company has 180 days to address the issues or face possible delisting.Recommended For YouMore Trending NewsSee More »About CRVO StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgCRVO--CervoMed Inc.Trending AnalysisTrending News